| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus
|
Hirano, Minato
|
|
|
200 |
C |
p.
|
article
|
| 2 |
Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors
|
Brown, Sook Kwan
|
|
|
200 |
C |
p.
|
article
|
| 3 |
Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses
|
Yamaoka, Satoko
|
|
|
200 |
C |
p.
|
article
|
| 4 |
Editorial Board
|
|
|
|
200 |
C |
p.
|
article
|
| 5 |
Erratum to “BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines” [Antivir. Res. 80 (2020) 104814]
|
Iqbal, Aqsa
|
|
|
200 |
C |
p.
|
article
|
| 6 |
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
|
Govorkova, Elena A.
|
|
|
200 |
C |
p.
|
article
|
| 7 |
Identification of novel Ebola virus inhibitors using biologically contained virus
|
Vanmechelen, Bert
|
|
|
200 |
C |
p.
|
article
|
| 8 |
Importin KPNA2 confers HIV-1 pre-integration complex nuclear import by interacting with the capsid protein
|
Song, Yanhui
|
|
|
200 |
C |
p.
|
article
|
| 9 |
Label-free duplex SAMDI-MS screen reveals novel SARS-CoV-2 3CLpro inhibitors
|
Scholle, Michael D.
|
|
|
200 |
C |
p.
|
article
|
| 10 |
Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain
|
Lai, Guan-Chun
|
|
|
200 |
C |
p.
|
article
|
| 11 |
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2
|
Pasquero, Selina
|
|
|
200 |
C |
p.
|
article
|
| 12 |
Phenotypic and genotypic acyclovir resistance surveillance of genital herpes simplex virus 2 in South Africa
|
Muller, Etienne E.
|
|
|
200 |
C |
p.
|
article
|
| 13 |
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis
|
Sachse, Martin
|
|
|
200 |
C |
p.
|
article
|
Journal description